EntryPoint Capital’s 4D Molecular Therapeutics FDMT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-55,539	Closed	-$309K	–	756
2024 Q4	$309K	Buy	55,539 +31,020	+127%	+$173K	0.13%	353
2024 Q3	$265K	Buy	24,519 +17,254	+237%	+$187K	0.15%	301
2024 Q2	$152K	Buy	+7,265	New	+$152K	0.22%	111